You are looking at all articles byPriya Shetty

Biomed Analysis: The social side of vaccine effectiveness

Social attitudes towards vaccines are hard to cram into a mathematical model, but scientists need to take them …

18/10/12

Biomed Analysis: India mustn't bow to patent pressure

The latest round of challenges to India's drug patent laws is a fight that must be won for the world's poor, says …

19/09/12

Biomed Analysis: 'Frugal' innovation for good health

The developing world needs support for low-tech health innovations that do not compromise on effectiveness, says …

15/08/12

Biomed Analysis: Indonesia needs a central science fund

Indonesia has a poor track record in funding R&D, stifling biomedical progress. Priya Shetty joins a call for …

20/07/12

Biomed Analysis: A cautious welcome for online trials

Online clinical trials hold promise for research but scientists should think hard before using them in poorer …

19/06/12

Biomed Analysis: Time for rights-based women's health

We need to revive the rights-based agenda and realign research priorities for women's health, says Priya Shetty.

23/05/12

Biomed Analysis: Tackling drug-resistant malaria

Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug's use must step …

19/04/12

Biomed Analysis: Why Africa must make its own drugs

There is a pressing need for Africa to bolster its pharmaceuticals industry, and that requires the right policy …

22/03/12

Biomed Analysis: Sustainability goals too light on health

The proposed Sustainable Development Goals need more focus on health to continue the progress achieved with MDGs, …

16/02/12

Biomed Analysis: Learning from India's polio success

India's carefully targeted strategy against polio holds lessons for other countries, and for other diseases, …

31/01/12

Biomed Analysis: Rolling out what works in mobile health

New funding and concrete results are paving the way for scaling up mhealth technologies — but carefully, …

21/12/11

Load more